References

1. Orejarena LA, Vidaillet HJ, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998;31:150-157.

2. Perry JC, Garson A, Jr. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 1990;16:1215-1220.

3. Ko JK, Deal BJ, Strasburger JF, Benson DW, Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992;69:1028-1032.

4. Deal BJ, Keane JF, Gillette PC, Garson A, Jr. Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985;5:130-135.

5. Chang RK, Wetzel GT, Shannon KM, Stevenson WG, Klitzner TS. Age- and anesthesia-related changes in accessory pathway conduction in children with Wolff-Parkinson-White syndrome. Am J Cardiol 1995;76:1074-1076.

6. Naheed ZJ, Strasburger JF, Benson DWJ, Deal BJ. Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol 1995;75:405-407.

7. Russell MW, Dorostkar PC, Dick M II. Incidence of catastrophic events associated with the Wolff-Parkinson-White syndrome in young patients: diagnostic and therapeutic dilemma. Circulation 1993; 88:I-484 (Abstract).

8. Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1996;27:690-695.

9. Levine JC, Walsh EP, Saul JP. Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome. Am J Cardiol 1993;72:689-693.

10. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 1996;19:95-106.

11. Fishberger SB, Colan SD, Saul JP, Mayer JEJ, Walsh EP. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol 1996;19:42-49.

12. Gikonyo BM, Dunnigan A, Benson DW, Jr. Cardiovascular collapse in infants: association with paroxysmal atrial tachycardia. Pediatrics 1985;76:922-926.

13. Losek JD, Endom E, Dietrich A, Stewart G, Zempsky W, Smith K. Adenosine and pediatric supraven-tricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med 1999;33:185-191.

14. Reed R, Falk JL, O'Brien J. Untoward reaction to adenosine therapy for supraventricular tachycardia. Am J Emerg Med 1991;9:566-570.

15. Radford D. Side effects of verapamil in infants. Arch Dis Child 1983;58:465-466.

16. Abinader E, Borochowitz Z, Berger A. A hemodynamic complication of verapamil therapy in a neonate. Helv Paediatr Acta 1981;36:451-455.

17. Rhodes LA, Walsh EP, Saul JP. Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J 1995;130:323-327.

18. Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996;131:66-72.

19. Fenrich ALJ, Perry JC, Friedman RA. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. J Am Coll Cardiol 1995;25:1195-1198.

20. Sasse M, Paul T, Bergmann P, Kallfelz HC. Sotalol associated torsades de pointes tachycardia in a

15-month-old child: successful therapy with magnesium aspartate. Pacing Clin Electrophysiol 1998;21:1164-1166.

21. Mulla N, Karpawich PP. Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolff-Parkinson-White syndrome treated with digoxin. Pediatr Emerg Care 1995;11:238-239.

22. Pfammatter JP, Paul T, Lehmann C, Kallfelz HC. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 1995;26:1002-1007.

23. Fish FA, Gillette PC, Benson DW, Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 1991;18:356-365.

24. Kugler JD, Danford DA, Deal BJ, Gillette PC, Perry JC, Silka MJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 1994;330:1481-1487.

25. Scheinman MM. NASPE Survey on Catheter Ablation. Pacing Clin Electrophysiol 1995;18:1474-1478.

26. Park JK, Halperin BD, McAnulty JH, Kron J, Silka MJ. Comparison of radiofrequency catheter ablation procedures in children, adolescents, and adults and the impact of accessory pathway location. Am J Cardiol 1994;74:786-789.

27. Danford DA, Kugler JD, Deal B, Case C, Friedman RA, Saul JP. The learning curve for radiofrequency ablation of tachyarrhythmias in pediatric patients. Participating members of the Pediatric Electrophysi-ology Society. Am J Cardiol 1995;75:587-590.

28. Kugler JD, Danford DA, Houston K, Felix G. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 1997;80:1438-1443.

29. Van Hare GF. Indications for radiofrequency ablation in the pediatric population. J Cardiovasc Electrophysiol 1997;8:952-962.

30. Erickson CC, Walsh EP, Triedman JK, Saul JP. Efficacy and safety of radiofrequency ablation in infants and young children <18 months of age. Am J Cardiol 1994;74:944-947.

31. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992;327:846-852.

32. Tanel RE, Triedman JK, Walsh EP, Epstein MR, DeLucca JM, Mayer JEJ, et al. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol 1997;8:812-817.

33. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-2934.

34. Silka MJ, Park JK. Mechanisms in current management of ventricular tachycardia in children. Heart Disease & Stroke 1994;3:372-376.

35. Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Haris L, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997;29:194-201.

36. Wolfe RR, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, Kidd L, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24hour ECG monitoring. Circulation 1993;87:I89-I101.

37. Gentles TL, Gauvreau K, Mayer JEJ, Fishberger SB, Burnett J, Colan SD, et al. Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg 1997;114:392-403.

38. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997;30:1374-1383.

39. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol 1999;10:1033-1044.

40. Chandar JS, Wolff GS, Garson AJ, Bell TJ, Beder SD, Bink B, et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol 1990;65:655-661.

41. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995;92:231-237.

42. Deal BJ, Miller SM, Scagliotti D, Prechel D, Gallastegui JL, Hariman RJ. Ventricular tachycardia in a young population without overt heart disease. Circulation 1986;73:1111-1118.

43. Pfammatter JP, Paul T. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European. J Am Coll Cardiol 1999;33:2067-2072.

44. Silka MJ. Implantable cardioverter-defibrillators in children. A perspective on current and future uses. J Electrocardiol 1996;(29 Suppl):223-225.

45. Epstein MR, Alexander ME, Saul JP, Triedman JK, Tanel RE, Walsh EP. Automatic implantable cardioverter defibrillators in the very young: has the technology not gone for enough? Circulation 1999;100:I-803(Abstract).

46. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Jr., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1998;31:1175-1209.

47. Kertesz NJ, Friedman RA, Colan SD, Walsh EP, Gajarski RJ, Gray PS, et al. Left ventricular mechanics and geometry in patients with congenital complete atrioventricular block. Circulation 1997;96:3430-3435.

48. Mazel JA, El-Sherif N, Buyon J, Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999;99:1914-1918.

49. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-1666.

50. Bharati S, McCue CM, Tingelstad JB, Mantakas M, Shiel F, Lev M. Lack of connection between the atria and the peripheral conduction system in a case of corrected transposition with congenital atrioventricular block. Am J Cardiol 1978;42:147-153.

51. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995;92:442-449.

52. Hofschire PJ, Nicoloff DM, Moller JH. Postoperative complete heart block in 64 children treated with and without cardiac pacing. Am J Cardiol 1977;39:559-562.

53. Hoffman JL. Heart block in congenital heart disease. Bull NY Acad Med 1971;47:885-904.

54. Weindling SN, Saul JP, Gamble WJ, Mayer JE, Wessel D, Walsh EP. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998;82:525-527.

55. Molina JE, Dunnigan AC, Crosson JE. Implantation of transvenous pacemakers in infants and small children. Ann Thorac Surg 1995;59:689-694.

56. Spotnitz HM. Transvenous pacing in infants and children with congenital heart disease. Ann Thorac Surg 1990;49:495-496.

57. Ragonese P, Guccione P, Drago F, Turchetta A, Calzolari A, Formigari R. Efficacy and safety of ventricular rate responsive pacing in children with complete atrioventricular block. Pacing Clin Electrophysiol 1994;17:603-610.

58. Graham TPJ, Bricker JT, James FW, Strong WB. 26th Bethesday conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol 1994;24:867-873.

59. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-856.

60. Dunnigan A, Benson W Jr, Benditt DG. Atrial flutter in infancy: diagnosis, clinical features, and treatment. Pediatrics 1985;75:725-729.

61. Naheed ZJ, Strasburger JF, Deal BJ, Benson DWJ, Gidding SS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996;27:1736-1740.

62. Guntheroth WG, Cyr DR, Shields LE, Nghiem HV. Rate-based management of fetal supraventricular tachycardia. Journal of Ultrasound in Medicine 1996;15:453-458.

63. Triedman JK, Walsh EP, Saul JP. Response of fetal tachycardia to transplacental procainamide therapy. Cardiol in the Young 1996;6:235-238.

64. Mangione R, Guyon F, Vergnaud A, Jimenez M, Saura R, Horovitz J. Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. Eur J Obstet Gynecol & Reprod Biol 1999;86:105-107.

65. Garson A Jr, Bink-Boelkens MTE, Hesslein PS, Hordorf AJ, Keane JF, Neches WH, et al. Atrial flutter in the young: a collaborative study in 380 cases. J Am Coll Cardiol 1985;6:871-878.

66. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlation with clinical, exercise, and echocardiography findings. Circulation 1995;91:2214-2219.

67. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnett J, Mayer JE J, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg 1997;113:80-86.

68. Gelatt M, Hamilton RM, McCrindle BW, Gow RM, Williams WG, Trusler GA, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994;24:1735-1741.

69. Feltes TF, Friedman RA. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol 1994;24:1365-1370.

70. Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of 'incisional' reentrant atrial tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical isthmus of conduction. Circulation 1996;93:502-512.

71. Baker BM, Lindsay BD, Bromberg B, Frazier DW, Cain ME, Smith JM. Catheter ablation of intraatrial reentrant tachycardias resulting from previous atrial surgery: locating and transecting the critical isthmus. J Am Coll Cardiol 1996;28:411-417.

72. Triedman JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 1997;30:1032-1038.

73. Cox JL, Sundt TM. The surgical management of atrial fibrillation. Am Rev Med 1997;48:511-523.

74. Haissaguerre M, Shah DC, Jais P, Clementy J. Role of catheter ablation for atrial fibrillation. Curr Opin Cardiol 1997;12:18-23.

75. Driscoll DJ, Jacobsen SJ, Porter CJ, Wollan PC. Syncope in children and adolescents. J Am Coll Cardiol 1997;29:1039-1045.

76. McHarg ML, Shinnar S, Rascoff H, Walsh CA. Syncope in childhood. Pediatr Cardiol 1997;18:367-371.

77. Tanel RE, Walsh EP. Syncope in the pediatric patient. Cardiol Clin 1997;15:277-294.

Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook


Post a comment